CureMatch is a startup based in the United States, 1 tracked investor.
Based in the United States, CureMatch is a startup. Brouky records 1 investor associated with the company.
CureMatch provides an AI-driven clinical decision support platform for oncology that analyzes patients' genomic and clinical data to generate and rank personalized cancer treatment options, including combination therapies, for use by oncologists and healthcare providers.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.